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Abstract
Background: In observational studies anaemia and iron deficiency are associated with cognitive deficits,
suggesting that iron supplementation may improve cognitive function. However, due to the potential for
confounding by socio-economic status in observational studies, this needs to be verified in data from randomised
controlled trials (RCTs).
Aim: To assess whether iron supplementation improved cognitive domains: concentration, intelligence, memory,
psychomotor skills and scholastic achievement.
Methodology: Searches included MEDLINE, EMBASE, PsychINFO, Cochrane CENTRAL and bibliographies (to
November 2008). Inclusion, data extraction and validity assessment were duplicated, and the meta-analysis used
the standardised mean difference (SMD). Subgrouping, sensitivity analysis, assessment of publication bias and
heterogeneity were employed.
Results: Fourteen RCTs of children aged 6+, adolescents and women were included; no RCTs in men or older
people were found. Iron supplementation improved attention and concentration irrespective of baseline iron status
(SMD 0.59, 95% CI 0.29 to 0.90) without heterogeneity. In anaemic groups supplementation improved intelligence
quotient (IQ) by 2.5 points (95% CI 1.24 to 3.76), but had no effect on non-anaemic participants, or on memory,
psychomotor skills or scholastic achievement. However, the funnel plot suggested modest publication bias. The
limited number of included studies were generally small, short and methodologically weak.
Conclusions: There was some evidence that iron supplementation improved attention, concentration and IQ, but
this requires confirmation with well-powered, blinded, independently funded RCTs of at least one year’s duration in
different age groups including children, adolescents, adults and older people, and across all levels of baseline iron
status.
Introduction
Anaemia, defined as ‘a reduction in the quantity of the
oxygen-carrying pigment haemoglobin in the blood’[1],
is a major global public health problem. It is estimated
that 25% of the world’s population have anaemia, and
approximately 50% of cases are due to iron deficiency
[2] where the anaemia is caused by an inadequate sup-
ply of iron to form haemoglobin (Hb). Lower concentra-
tions of Hb result in a number of symptoms such as
weakness and general fatigue, and adverse effects on the
immune system [3]. In more severe cases a need to
increase cardiac output leads to dyspnoea (shortness of
breath), palpitations and heart failure, and in pregnancy
an increased risk of pre-term delivery and low birth
weight [4].
Many factors may contribute to the risk of developing
iron deficiency anaemia (IDA), including low iron intake
and poor absorption of iron (from diets high in iron
chelators such as phenolic compounds and phytate, or
low in ascorbic acid and meat/fish), and high iron
demand (during menstruation, pregnancy and growth
spurts). These result in a higher risk of IDA at 6-12
months of age, during adolescence (especially in girls at
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the onset of menstruation), women of child-bearing age
(especially during pregnancy), and older people (when
diets may be less nutritious and malabsorption
increases) [2]. There is also a higher risk of anaemia in
the presence of chronic inflammatory states, which are
common in the elderly, mediated by raised hepcidin
expression. Additional risk factors include heavy men-
strual blood loss, parasitic infections, acute and chronic
infections, other micronutrient deficiencies, and haemo-
globinopathies [2].
Cognition is defined as ‘The mental processes by
which knowledge is acquired. These include perception,
reasoning, acts of creativity, problem solving, and possi-
bly intuition.’[1] Cognition is important for quality of
life, such that impaired cognitive function is correlated
with poorer quality of life e.g. in stroke patients [5] and
poorer life prospects.
The effect of iron supplementation on a range of
health outcomes in infants and young children has been
well explored. It is estimated that 47% of pre-school
children worldwide have anaemia, the highest prevalence
of any population group [2]. Longitudinal studies show
that iron deficiency in infancy is related to poorer cogni-
tion in childhood [6]. One systematic review that
included seven RCTs on the effects of supplementary
iron in young children with anaemia or iron deficiency
found no evidence of an effect of iron supplementation
on psychomotor development [7], while another includ-
ing seventeen RCTs in children of any age and with any
initial iron status, found that iron supplementation was
not associated with improved mental development
scores in children under 5 years [8], or with improved
physical growth [9]. A more recent systematic review
addressed a range of health risks and benefits of iron
supplementation in infants and children aged under 5
years [10], finding that supplementation led to improve-
ments in cognition and motor development in anaemic
and iron-deficient children, but was associated with
increased risk of death in areas with endemic malaria.
As animal studies have shown that in the developing
brain iron deficiency is associated with hypomyelination
of neurones [11], effects on the dopaminergic system
and a deficiency of enzymes involved in the develop-
ment of parts of the brain important for cognitive func-
tions such as memory (e.g. the hippocampus) [12],
deficiency and supplementation may have different
effects on infants and young children than in other
population groups. For this reason, and because there
are already several reviews covering this group, we have
excluded studies on infants and young children from
this review.
Older children and adolescents are less at risk of anae-
mia than pre-school children, but global statistics indi-
cate that approximately 25% of older children have
anaemia, as do, 30% of non-pregnant women and 42%
pregnant women, and 17% of elderly people (rising to
40-50% of those admitted to hospital or living in nursing
homes), demonstrating that it is a very large and impor-
tant health problem [2,13]. While observational evidence
suggests a strong link between iron deficiency or anae-
mia and cognitive deficit, the evidence of a causal link
through intervention studies is limited. In order to max-
imise the power of the conducted RCTs to address the
effect of iron supplementation, we conducted a systema-
tic review and meta-analysis of the literature. This study
aims to pool data from all available high quality RCTs
to ascertain whether there is a beneficial effect of iron
supplementation on cognition in humans aged 6 years
and above, whether this differs according to baseline
iron status, and whether it is different in various age
groups. The systematic review is presented in a form
consistent with the PRISMA Statement (see Additional
File 1), no protocol for this review has been published
or registered[14]
Materials and methods
Search methods
Structured electronic searches were carried out from
inception to November 2008 on MEDLINE, EMBASE
(both on Ovid), PsychINFO and Cochrane CENTRAL.
The search included text and indexing terms, truncation
and Boolean operators in the format ‘ [cognition text
and indexing terms] and [iron text and indexing terms]
and [RCT filter]’. The full MEDLINE search is shown in
Additional File 2. The search was not limited by lan-
guage. At least two reviewers each independently
scanned identified titles and abstracts, ordering papers
that either reviewer felt might fulfil the inclusion cri-
teria. The reference lists of included studies and relevant
reviews were also checked for relevant studies. Several
authors were contacted to query inclusion criteria, and
one study [15] was included on this basis.
Inclusion criteria, data extraction and validity assessment
The inclusion criteria were that participants were
human and aged at least 6 years, participants had to be
randomised to an iron supplementation (as a fortified
food or a supplement) vs. a control (placebo or no inter-
vention) arm, duration of intervention was at least 4
weeks, the additive effect of iron had to be clear (so
multiple nutrient supplements compared with no sup-
plementation was not acceptable), and some objective
measure of cognitive performance had to be assessed.
At least two reviewers independently assessed each full
text study for inclusion, and disagreements were settled
through group discussion. Papers were grouped into
individual studies, and then data extraction and assess-
ment of validity of studies were carried out
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independently at least in duplicate (sometimes triplicate)
onto a standardised data extraction form. The com-
pleted forms were discussed within the group, and dis-
agreements settled with reference to a third reviewer or
the wider team. Data extracted included methodological
details, participant characteristics and flow, intervention
and control details (including type and dose of iron, as
well as similarity to the control), outcome data; includ-
ing primary outcomes (measurements of cognition), sec-
ondary outcomes (e.g. adverse effects or side effects of
intervention, and changes in serum Hb and serum ferri-
tin (SF)), and issues to check with study authors.
Primary outcomes were characterised as belonging
primarily to one of the following cognitive domains:
intelligence, memory, concentration or psychomotor
skills, or to scholastic achievement which may reflect a
mixture of these skills, and is the most ecologically valid
measure of performance. Where studies provided several
different tests that fell within a single domain the out-
come used in analysis was that which was shared with
other published studies. For scholastic achievement out-
comes testing mathematical skills were prioritised to
enhance the objectivity of measurement. For continuous
primary and secondary review outcomes mean change
in the outcome from baseline to latest duration, stan-
dard deviation of that change and the number of partici-
pants were recorded for the intervention group and
control group. Where change data were not provided,
absolute measurements from the end of the intervention
period were recorded in their place. Where variances
were provided as standard errors they were converted to
standard deviations, and where tests showed better cog-
nition with a lower score the signs of the means were
reversed. Where data were provided in subgroups (for
example for those anaemic or not anaemic at baseline),
these data were extracted and used in preference to
grouped data. In studies where two different doses or
frequencies of iron supplementation were used with
only one control group then data from the two interven-
tion arms were combined using the methods recom-
mended in the Cochrane Handbook [16].
Assessment of validity was included in the main data
extraction form and included whether randomisation
was described, allocation concealment, masking of the
participants, researcher(s) and outcome assessor(s),
change in iron status (described positively where there
were statistically significant differences in Hb or SF
between iron and placebo groups at the end of the
study OR, if there was no information provided on this,
the intervention duration was at least 12 weeks), inclu-
sion of all those randomised in the outcomes, and
potential funding bias.
Authors of studies which did not contain sufficient
data to be included in data analysis were contacted via
e-mail and by letter and asked to provide raw outcome
data from their study.
Analysis
Data on the characteristics and validity of the included
studies were tabulated (see Tables 1 and 2). The com-
puter software ‘Review Manager 5’ was used to meta-
analyse data within the cognitive domains of intelli-
gence, memory, concentration, scholastic achievement
and psychomotor skills. Subgrouping was by baseline
iron status (as defined by the World Health Organisa-
tion) and by age group [17]. Anaemia was defined as
Hb levels <11.5 g/dl in children aged 6-12, <12 g/dl
children aged 13-14 and non-pregnant adult women,
<13 g/dl in adult men and <11 g/dl in pregnant
women. Iron deficiency was defined as not having
anaemia, but having SF <15 μg/L, the remainder were
considered to be iron replete at baseline. Where SF
was not reported and participants were not anaemic
they were categorised as ‘iron deficient and/or replete’.
Study populations were described as children (aged 6-
18), pre-menopausal women, post-menopausal women,
or men.
Meta-analysis used the inverse variance method.
Because of the nature of the different cognitive test
scoring systems, which used very different scales, stan-
dardised mean differences (SMD) were used in random
effects meta-analysis. This allowed assessment of
whether statistically significant effects were found in the
pooled data, but did not provide outcome measures
meaningful on any particular scale. Sensitivity analysis
was employed to check the results of the meta-analyses,
removing studies where it was not clear that iron status
had altered during the study. The presence (or not) of
publication bias was assessed using a funnel plot and
studies that assessed outcomes that could not be
included in the meta-analyses were discussed alongside
the meta-analysis results. The importance of differences
between studies, heterogeneity, was assessed using the I2
statistic [18].
Results
Review process
From the 1554 titles and abstracts identified as sepa-
rate papers (following de-duplication of the original
2247 records) via electronic and reference searching,
14 were included in the review, see Figure 1. Of these,
9 studies provided data which could be used in analy-
sis [15,19-26] the others provided data as z-scores or
without necessary data on variance. None of the stu-
dies identified required translation. We contacted
authors of 9 of the 14 studies to request additional
information, and all useful data received was included
in the analysis.
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Table 1 Characteristics of included studies.
Study Name n Population Dose &
type of
oral iron
Baseline Iron Status Study
duratn,
Drop-
outs
Cognitive tests*
Beard 2005
[19,45]
Iron
34
Pl 30
S Africa-mothers, 18-
30 yrs
Pre-menopausal
women
125 mg/d
as pills
Anaemic - Hb 9-11.5 g/dl, SF 10-12 μg/L 29 wks,
Iron 2
Pl 4
Raven’s CPM (IQ), Wechsler’s DS
(M, Ps)
Bruner 1996
[30,46]
Iron
40
Pl 41
USA-adolescents,
school, mean age
16.2 and 15.7
Children 6-18
260 mg/d
EFe as
capsules
Iron Defic - Hb>11.5 g/dl (Af American),
Hb>12 g/dl (white), SF<12 μg/L for all
8 wks,
Iron 1
Pl 2
Visual Search and Attention (AC),
Hopkin’s Verbal Learning Test (M),
DS Modalities (Ps), Attention.
Elwood
1970 [20]
Iron
26
Pl 21
UK - women >20 yrs
Pre-menopausal
women
150 mg/d
as tablets
Anaemic - HB<10.5 g/dl 8 wks,
Iron 0
Pl 0
Mazes test (AC), Serial Sevens (M),
Peg board (Ps), E test, card sorter.
Gopaldas
1985
[21,47-49]
Iron
32
Pl 16
India-School boys-
recipients of free
noon meal, 8-15 yrs
Children 6-18
30 or 40
mg/d as
tablets
Anaemic - Hb<10.5 g/dl, Iron Defic and/
or Repl- rest
8.5 wks,
Iron 0
Pl 0
Mazes test (AC), Visual Memory
Test (M), Wechsler’s Digit span
(Ps), Clerical task
Groner 1986
[22]
Iron
19
Pl 19
USA-pregnant
women, 14-24 yrs
Pre-menopausal
women
60 mg/d
EFe as
capsules
Iron repl - mean Hb>12 g/dl, SF 40-60
μg/L
4 wks,
Iron 3
Pl 10
Vocab (IQ), DS (M, Ps), Arithmetic
(SA), Consonant trigram, Rey AVL,
Digit Span
Kashyup
1987 [23,49]
Iron
83
Pl 83
India-School girls,
under privileged, 8-
15 yrs
Children 6-18
60 mg/d
EFe as
tablets
Anaemic - Hb<10.5 g/dl, Iron Defic and/
or Repl-rest
17.2 wks,
Iron 18
Pl 18
Mazes test (AC), Visual Memory
(M), Wechsler’s Digit span (Ps),
Clerical
Kordas 2005
[32,50,51]
Iron
303
Pl
299
Mexico-school
children, mean age
7.0
Children 6-18
30 mg/d
as tablets
Iron Defic and/or Repl - Hb>9 g/dl 21 wks,
Iron 38
Pl 49
Distractibility (AC), Peabody PV (IQ),
Vis Memory (M), Maths (SA),
Sternberg**
Lambert et
al., 2002 [27]
Iron
57
Pl 59
New Zealand-female
high school
students, 12.5-17.9
yrs
Children 6-18
105 mg/d
EFe as
tablets
Iron defic - Hb>12 g/dl, SF<12 μg/L 8 wks,
5 across
whole
study
Visual Search and Attention (AC),
Hopkin’s Verbal Learning (M),
Stroop task, Reading span
Lynn &
Harland
1998 [15]
Iron
208
Pl
205
England - teenagers
at 7 comprehensive
schools, 12-16 yrs
Children 6-18
17 mg/d
EFe as
tablets
Iron Defic - any Hb, SF<12 μg/L ??and???
Iron Repl - the rest
16 wks,
Unclear,
~200
over
study?
Raven’s CPM (IQ)
Murray-Kolb
et al 2007
[31]
Iron
76
Pl 76
USA-Women, aged
18-35 yrs
Pre-menopausal
women
60 mg/d
EFe as
pills
Anaemic - Hb 10.5-11.9 g/dl plus 2 aFeSIs,
Iron Defic - Hb = 12 g/dl plus 2 aFeSIs,
Iron Repl - Hb = 12 g/dl without 2 aFeSIs
16 wks,
Iron 20
Pl 19
Cog Abilities-attention (AC), Cog
Abilities - memory (M), Cog Abilities
- learning (SA), Shipley Inst Scale
(IQ)
Pollitt 1989
[24]
Iron
678
Pl
678
Thailand-school
children, 9-12 yrs
Children 6-18
4 mg/kg/
d EFe as
tablets
Anaemic Hb<12 g/dl and SF<10 μg/L or
TS<16%, Iron Defic Hb>12 g/dl and
SF<10 μg/L or TS<16%, Iron Repl - rest
16 wks,
Not
reported
Raven’s CPM (IQ), Mathematics
(SA), Thai language
Soemantri
1985 [29,52]
Iron
59
Pl 60
Indonesia-primary
school children,
mean age 10.7 to
11.1 yrs
Children 6-18
2 mg/kg/
d EFe as
tablets
Anaemic - Hb<11 g/dl, TS<15%, Iron Repl
- Hb>12 g/dl, TS>20%
13 wks,
Iron 0
Pl 0
Raven’s CPM (IQ), Bourden-
wisconsin concentration, Maths,
Language, Biology, social science
Soemantri
1989 [25]
Iron
71
Pl 59
Indonesia-primary
school children,
mean age 10.4
Children 6-18
2 mg/kg/
d EFe
tablets
Anaemic - Hb<11 g/dl, TS<12%, Iron Repl
- Hb>12 g/dl. TS <20%
13 wks,
Iron 0
Pl 0
Raven’s CPM (IQ), Maths (SA),
Language, Biology, social science
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Study characteristics
The characteristics of the included studies are shown in
Table 1 (including data from all relevant located publi-
cations of each study and any author information pro-
vided). Seven of the studies were carried out in
developing countries (2 in Thailand, 2 in Indonesia, 1 in
Mexico, 2 India) and 7 in developed countries (3 in the
USA, 2 in the UK, 1 in South Africa and 1 in New Zeal-
and). Most studies were carried out on children and/or
adolescents, but studies also included pregnant women,
mothers with young infants and anaemic non-pregnant
women. No studies included men, post-menopausal
women or the elderly, and no studies gave nutrients
additional to iron in the intervention and placebo
tablets. Studies ran from 4 to 29 weeks, so were of vari-
able and relatively short duration.
The three forms of iron used were ferrous sulphate,
ferrous carbonate and ferrous fumarate (one study did
not mention the type of iron used [27]). All included
studies used an oral iron supplement in the form of
‘pills’, ‘capsules’ or ‘tablets’, none gave supplemented
foods.
A plethora of objective tests were used, measuring the
specified domains of cognition (actual tests used in each
study are detailed in Table 1). Tests were administrated
by trained field workers, researchers or psychologists in
three studies, a group of researchers and teachers or
trained testers and school staff in two studies, by the
school in one study and self-administered in one study
(with no details reported in the remainder). In three stu-
dies the tests were administered individually while the
remainder did not state group or individual administra-
tion. One study reported that the tests were completed
with paper and pencil, one had computerised tests, one
had verbal and computer testing, and one a mixture of
paper and computerised formats.
Validity of studies
Study validity is reported in Table 2 (including data
from all available publications and contact with authors).
The process of randomisation was described in 5 of 14
studies, partially described in 3, not in 6. Allocation
concealment was carried out and reported in only 1
study, and was unclear in the remainder. The researcher
was clearly masked to the intervention in 6 studies, the
outcome assessors in 6 studies and participants in 13
studies, while in most of the remaining cases masking
was unclear. There were dropouts in 9 studies (none in
4 studies, unclear in another, see Table 1), while all
those randomised were included in outcomes in one
study (unclear in 2, not in the remainder, see Table 2),
3 studies fully reported the reasons for dropouts and 5
studies partially reported them. There was moderate
potential for funding bias in 9 studies, a high risk of
funding bias in 4 studies and a low risk of funding bias
in only one study (see below Table 2 for details of how
this was assessed). Iron status changed in the interven-
tion relative to the control group, or intervention lasted
at least 12 weeks, in 20 of the 23 included arms, unclear
in one, and not in two arms. Only one arm for which
data were included in the meta-analysis was unclear
about iron status change and so data from this study
were excluded in sensitivity analyses [20].
Outcomes
Attention/Concentration
The effect of iron supplementation on attention or con-
centration was assessed in 3 groups of anaemic partici-
pants (146 people) and two groups of iron deficient
and/or replete participants (33 people), see Figure 2.
Iron supplementation appeared to have statistically sig-
nificant beneficial effects on attention or concentration
overall (SMD 0.59, 95% CI 0.29 to 0.90, peffect = 0.0002,
n = 179, I2 0%, pheterogeneity 0.71) as well as in both sub-
groups, without any suggestion of heterogeneity. This
standardized mean difference could be interpreted as a
‘moderate effect’ [28]. Improvement in attention and
concentration occurs in the set of studies of children
aged 6-18 (with no suggestion of heterogeneity), but the
only study of pre-menopausal women does not suggest
a statistically significant effect on its own (see Table 3).
The effect is weakened, but remains statistically signifi-
cant when the data from the one study that did not
clearly improve iron status [20] were removed.
Table 1: Characteristics of included studies. (Continued)
Sungthong
2004 [26,53]
Iron/
d
112
Iron/
wk
102
Pl 99
Thailand-School
children, mean age
9.6 to 9.7
Children 6-18
60 mg/d
or/wk
EFe,
tablets
Iron Repl - Hb>8 g/dl, SF>20 μg/L 16 wks,
Iron/d 1
Iron/wk 4
Pl 1
Test of Non-Verbal Intelligence
(IQ), Maths (SA), Thai Language
*tests in bold have been used in the analysis
** Plus Figure match & design, Stimulus discrimination, Cognitive abilities, Visual search, Sequencing
Hb: haemoglobin, TS: transferrin saturation, SF: serum ferritin, EFe: elemental iron, aFeSI: abnormal iron status indicators, Pl: placebo, AC: Attention and
concentration, IQ: Intelligence quotient, M: memory, Ps: psychomotor, SA: Scholastic Achievement, Raven’s CPM: Raven’s Colour Progressive Matrices, Peabody PV:
Peabody Picture Vocabulary, Rey AVL: Rey Auditory Verbal Learning, Digit Symbol: DS, Repl: repletion, Defic: deficient
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We located five studies that fulfilled the review
inclusion criteria, assessed effects of iron on attention
and concentration, but which provided data in a for-
mat that could not be included in meta-analysis (5 stu-
dies, including 8 intervention arms). One study in
Indonesian primary school children [29] found an
improvement in attention and concentration related to
iron supplementation, while the remaining four studies
(in US adolescents and pre-menopausal women, New
Zealand teenagers and Mexican primary school chil-
dren) found no statistically significant effects on mea-
sures of attention or concentration [27,30-32]. It is not
clear whether inclusion of the data from these five stu-
dies would have reduced or reinforced the suggested
improvement in attention and concentration with iron
supplementation.
Intelligence
The effect of iron on intelligence quotient (IQ) was
assessed in three groups of anaemic participants, two of
iron deficient people and six groups of those who were
iron replete at baseline, see Figure 3. Overall there was no
evidence of an effect of iron supplementation on intelli-
gence (SMD 0.10, 95% CI -0.14 to 0.33, peffect = 0.43, n =
2365, I2 81%, pheterogeneity <0.00001), but there was evi-
dence of an effect on people who were anaemic at baseline
(SMD 0.54, 95% CI 0.26 to 0.81, peffect = 0.0002, n = 209,
I2 0%, pheterogeneity 0.79), a moderate effect. These anaemic
participants included African mothers with young children
and school aged children from Thailand and Indonesia.
Subgrouping by age group does not suggest any effect on
intelligence in children, but does suggest a positive effect
of iron supplementation in pre-menopausal women, with
Table 2 Validity characteristics of included studies
Random-isation
Described/
Allocation
Concealment
Researcher/Outcome
Assessor/Participants
Masked to
intervention
Change in iron status
OR 12+ wks?*
All those randomised
included in outcomes?/
Reason for dropouts
reported?
Potential
for
funding
bias**
Study data
useable in
meta-
analysis?
Beard 2005 Partially/Unclear Unclear/Unclear/Yes Yes (SF, 29 wks) No/Partially Moderate Yes
Bruner 1996 Yes/Unclear Yes/Unclear/Yes Yes (Hb & SF) No/Yes High No (no raw
data, only
regression)
Elwood
1970
No/Unclear Unclear/Yes/Yes Unclear (p-values not
presented)
No/Partially High Yes
Gopaldas
1985
Partially/Unclear No/No/Yes Anaemic & Iron repl: Yes
(Hb)
Yes/Yes (no drop-outs) High Yes
Groner 1986 No/Unclear Yes/Yes/Yes Yes (Hb) No/Yes Moderate Yes
Kashyap
1987
Partially/Unclear Unclear/Unclear/Yes Anaemic & Iron repl: Yes
(Hb, 17 wks)
No/Partially Moderate Yes
Kordas 2005 Yes/Unclear Yes/Yes/Yes Yes (21 wks) No/Partially Moderate No (only z-
scores)
Lambert
2002
No/Unclear Yes/Unclear/Yes Yes (SF, not Hb) No/No Moderate No (no
variance data)
Lynn &
Harland
1998
Yes/Unclear Yes/Yes/Yes Iron Defic & Iron repl:
Yes (16 wks)
Unclear/No High Yes
Murray-Kolb
2007
Yes/Unclear No/Yes/Yes Anaemic & Iron repl: Yes
(SF, not Hb, 16 wks),Iron
defic: No (not SF or Hb)
No/Partially Moderate No (reported
only as z-
scores)
Pollitt 1989 No/Unclear Unclear/Unclear/Yes Anaemic, Iron defic &
Iron repl: Yes (Hb, SF, 16
wks)
No/No Moderate Yes
Soemantri
1985
No/Unclear Unclear/Unclear/Unclear Anaemic: Yes (Hb, 13
wks)
Iron repl: No (Hb)
Unclear/No Moderate No (no
variance or
SD data)
Soemantri
1989
No/Unclear Unclear/Unclear/Yes Anaemic & Iron repl: Yes
(Hb, 13 wks)
No/No Moderate Yes
Sungthong
2004
Yes/Yes Yes/Yes/Yes Yes (SF & Hb, 16 wks) No/Yes Low Yes
* Iron status was said to have changed if there were statistically significant differences in Hb or SF between iron and placebo groups at the end of the study or,
where no data were provided, if the intervention period was at least 12 weeks long.
** Potential for funding bias was assessed as follows: low (when funders were clearly not industry-related, no authors worked for industry and there was no
suggestion that products were donated by industry); high (when non-industry funding was reported, or when funding was not mentioned); moderate in all other
studies.
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no heterogeneity (Table 3). All three studies used Raven’s
Colour Progressive Matrices to measure IQ. We trans-
formed the unitless SMD back to the IQ scale used with
Raven’s Colour Progressive Matrices by multiplying it by
the among-person standard deviation for the scale within
the Pollitt 1989 study (as this was the largest study in
anaemic participants), and based the variance on the
pooled standard deviation of the same study as suggested
by the Cochrane Handbook, section 12.6.4 [16]. The effect
of iron supplementation in those with anaemia was
equivalent to an improvement of 2.50 (MD 2.50, 95% CI
1.24 to 3.76) in IQ as compared with placebo.
The data were highly heterogeneous in the few iron
deficient participants and suggested no effect in the
more than 2000 participants who were iron replete at
baseline. Sensitivity analysis, removing the study where
it was not clear whether iron status improved with sup-
plementation, did not alter the overall non-significance
of the effect of iron supplementation on intelligence, or
any of the subgroups.
To assess the likelihood of publication bias being
present in the data we created a funnel plot using the
data on intelligence (as this was the outcome with
most studies included in meta-analysis). The funnel
plot did suggest some risk of publication bias, see Fig-
ure 4, but it is not clear whether this could have been
accounted for by the studies that we located but that
could not be included in the meta-analysis. The three
included studies (six intervention arms, of which two
were in anaemic participants) that assessed the effect
of iron supplementation on intelligence but could not
be included in the analysis all found no statistically
significant differences in intelligence between the
intervention and control groups. It is unclear how
inclusion of these data would affect the overall
results.
Memory
Four studies addressed the effect of iron supplementa-
tion on memory in anaemic participants, none in iron
deficient people, 2 in those iron deficient and/or replete
and 1 in those iron replete at baseline, see Figure 5.
There was no evidence overall (SMD 0.17, 95% CI -0.12
to 0.46, peffect = 0.25, n = 255, I
2 17%, pheterogeneity 0.30)
or in any subgroup, that iron supplementation improved
memory. There was no suggestion of important hetero-
geneity, and removing the one study [20] without a
clear effect on iron status made no difference to the
overall effect of iron. Subgrouping by age group sug-
gested no differential effects by age (Table 3). Four
further studies which measured effects on memory did
not provide data for meta-analysis. One of these studies
reported finding a statistically significant effect of iron
supplementation on memory, the others did not suggest
a statistically significant effect [30].
Titles and abstracts from electronic 
(MEDLINE, EMBASE, Cochrane and 
PsychInfo, to Nov 2008): n=2205 
Records after duplicates removed: n=1554 
Additional records identified through 
other sources (bibliographic searches): 
n=42
Full papers and conference abstracts 
assessed for inclusion: 101 
Full papers and conference abstracts 
included in qualitative synthesis: 22 
Individual studies included: 14 
Arms included: 23 
Papers excluded as not RCT, 
participants not humans aged 6+, 
intervention not iron vs. placebo, or 
objective measure of cognitive 
performance not assessed: 78
Records excluded; n=1453 Titles and abstracts screened; 
n=1554 
Studies included in meta-analyses: 9  
Arms included in meta-analyses: 14 
Figure 1 PRISMA study flow diagram for the systematic review [14].
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Psychomotor function
The domain of psychomotor function was investigated
by 4 studies in those anaemic at baseline, 2 in iron defi-
cient and/or replete participants and 1 in iron replete
participants (none in iron deficient participants), Figure
6. There was no suggestion of an effect of iron supple-
mentation on psychomotor function overall (SMD 0.13,
95% CI -0.12 to 0.39, peffect = 0.31, n = 255, I
2 0%, pheter-
ogeneity 0.64) with no suggestion of heterogeneity. Simi-
larly there was no significant effect on the subgroups of
anaemic or iron replete participants, or in subgroups of
children or pre-menopausal women. Removing studies
without a clear effect on iron status did not alter these
results. One study which did not provide data for the
meta-analysis measured psychomotor function, and
found no effects on it of iron supplementation [30].
Scholastic achievement
The effects of iron supplementation on scholastic
achievement appeared highly heterogeneous - two stu-
dies showed statistically significant improvement, and
two showed statistically significant impairment to scho-
lastic achievement from iron supplementation compared
with the control group at end of study. Overall, there
was no suggestion of a significant effect (SMD 0.12, 95%
CI -0.49 to 0.72, peffect = 0.70, n = 1824, I
2 96%, phetero-
geneity <0.00001), Figure 7. There was no significant
effect in the subgroup of participants with anaemia at
baseline, or who were iron replete at baseline, or in chil-
dren or pre-menopausal women, but in the one study in
iron deficient participants iron appeared to worsen
scholastic achievement. Removing studies where the
effect of supplementation on iron status was not clear
resulted in no changes in statistical significance except
that the one study remaining in the subgroup with anae-
mia at baseline suggested a harmful effect of iron sup-
plementation on scholastic achievement. Three studies
which did not provide data for the meta-analysis
assessed effects on scholastic achievement. One study
found significant improvements [29], the others found
no effects of iron supplementation.
Adverse effects
Adverse effects of iron supplementation were not well
reported in the included studies, with the exception of
Bruner et al [30], which mentions ‘constipation’. In the
1475 participants randomised within studies that
reported dropouts by arm, there was a relative risk of
dropping out of 0.80 (95% CI 0.62 to 1.03) in iron sup-
plemented compared to placebo arms.
Discussion
This systematic review of 14 studies has assessed the
effects of iron supplementation on cognition in males
Table 3 Meta-analysis, subgrouping by age group. SMD analysis of the effect of iron supplementation on cognitive
domains
Cognitive domain Age group Standardised mean difference (95%
CI)
Number of participants/
studies
Heterogeneity - I2
test
Attention &
concentration
Children aged 6-18 0.62 (0.26 to 0.98)* 132/2 (4 arms)** 0%
Pre-menopausal
women
0.53 (-0.06 to 1.12) 47/1 Not relevant
Intelligence Children aged 6-18 0.02 (-0.22 to 0.27) 2289/4 (9 arms)** 82%
Pre-menopausal
women
0.62 (0.15 to 1.10)* 76/2 0%
Memory Children aged 6-18 0.33 (-0.19 to 0.85) 132/2 (4 arms)** 35%
Pre-menopausal
women
0.09 (-0.31 to 0.50) 123/3 18%
Psychomotor Children aged 6-18 0.19 (-0.17 to 0.54) 132/2 (4 arms)** 0%
Pre-menopausal
women
0.09 (-0.32 to 0.50) 123/3 21%
Scholastic aptitude Children aged 6-18 0.03 (-0.63 to 0.69) 1799/3 (6 arms)** 96%
Pre-menopausal
women
0.77 (-0.08 to 1.62) 25/1 Not relevant
* p < 0.05
** Two studies included 3 sets of participants defined by baseline iron status [1524], and two further studies included 2 sets of participants defined by baseline
iron status [2123], these arms were entered separately into the meta-analysis.
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Figure 3 Forest plot, SMD analysis of the effect of iron supplementation on intelligence.
Figure 2 Forest plot, SMD analysis of the effect of iron supplementation on attention and concentration.
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and females aged 6 years and older. The participants of
the included studies were most often children or adoles-
cents (10 studies, of which 7 were from developing
countries). The remaining studies were in women, gen-
erally younger women - only one study included women
over 35 years old. No studies included men, post-meno-
pausal women or the elderly.
We found some evidence that iron supplementation
improved attention and concentration in adolescents
and women at all levels of iron status at baseline over
periods of 8-17 weeks. Iron supplementation also
improved IQ in children and women with anaemia at
baseline over 13-29 weeks, but had no effects on mem-
ory, psychomotor skills or scholastic achievement. How-
ever, most studies were small, methodologically weak
and there was evidence of publication bias.
There were over 1500 children and adolescents in the
iron replete subgroup assessing effects on both intelli-
gence and scholastic ability, suggesting that this group
was adequately powered to detect an effect, and that the
lack of effect observed in these iron replete samples is
likely to be reliable over 4-29 weeks. However, the
included studies were of short duration and for all out-
comes effects may be greater, or different, in the longer
term. In other subgroups where no effects are seen, this
may be due to a lack of power and/or short duration,
making it less likely that any true effects can be
discerned.
Comparison with other literature
Benton found repeated and consistent reports in both
developing and developed countries of associations
between iron status and intellectual ability or scholastic
performance, with more subtle effects with less severe
iron deficiency [33]. A previous review found that iron
supplementation appeared to improve mental develop-
ment scores in older children, but did not address the
different domains of cognition [8]. We have extended
this analysis, confirming that iron supplementation
appears to improve attention and concentration in older
children and adults and improves certain measures of
intelligence quotient in those with anaemia at baseline.
However, there is no evidence that other cognitive
domains are affected by iron supplementation.
Figure 4 Funnel plot, based on studies with data on intelligence.
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Severe anaemia results in increased mortality in
women and babies [2,4]. A large and comprehensive sys-
tematic review of the effect of routine oral iron supple-
mentation during pregnancy included 40 RCTs or
quasi-randomised trials, but did not identify cognitive
outcomes in mothers [34]. No other systematic reviews
of the effects of iron supplementation on cognition in
adults were identified, although there is reasonable evi-
dence of the effects of iron deficiency on work capacity,
suggesting that IDA reduces aerobic capacity, with less
clear effects on endurance capacity and voluntary activ-
ity [35].
As in previous reviews, no RCTs assessing the effect
of iron supplementation on cognition in the elderly
were found [36], and data on adults generally were
scarce. A systematic review found only one case con-
trol study that addressed the relationship between
anaemia and cognition [36], finding that Alzheimer’s
disease was twice as prevalent in older people with
anaemia. Another more recent systematic review of
three longitudinal studies found a doubling of the risk
of dementia in those with anaemia [37]. This was con-
firmed by a recent study which suggested that IDA is
associated with poorer cognitive function over and
above the already elevated risk of cognitive decline in
this group [38].
When data were combined from studies in children
and pre-menopausal women the lack of heterogeneity
between studies assessing attention and concentration
suggested that similar mechanisms may be determining
the effects of iron supplementation on cognition across
these age groups.
Strengths and weaknesses of the review
Study duration of included studies is of concern, the
shortest included studies were only 4 weeks in duration,
and five included studies were shorter than 12 weeks.
Twelve weeks of supplementation is sufficient to alter
iron status, and so alter oxygen supply to the tissues,
but shorter studies may not be long enough to ensure
this has occurred. It is possible that including studies of
too short duration will dilute effects, and potentially
negate any effect of iron on cognition. To check this we
performed sensitivity analysis, removing studies that did
not show statistically significant improvements in Hb or
SF in the intervention group compared to the control,
or were shorter than 12 weeks duration. This did not
alter either the significant effects on the attention and
concentration or intelligence, or the lack of significance
in other groups, suggesting that the included studies
were long enough to ensure improved iron status in
intervention arms.
Figure 5 Forest plot, SMD analysis of the effect of iron supplementation on memory.
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Figure 7 Forest plot, SMD analysis of the effect of iron supplementation on scholastic ability.
Figure 6 Forest plot, SMD analysis of the effect of iron supplementation on psychomotor skills.
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However, for outcomes such as scholastic achieve-
ment, improvement may require a much longer inter-
vention period than the time necessary to replete Hb
levels. Even when SF and/or Hb concentration has
improved, a further period may be required for perfor-
mance improvement to occur. This is particularly rele-
vant in relation to scholastic achievement where iron
status at learning may be different from iron status at
retrieval of information or assessment of performance.
This could result in a lack of effect of iron supplementa-
tion being detected on tests of this type. For these out-
comes even studies of 29 weeks (the longest of our
included studies) may not be sufficient to see important
effects. The effects of longer term studies are unclear
and this is an important area for future research.
Adverse effects have been associated with iron supple-
mentation, for example increasing the risk of developing
diarrhoea [10,39] or constipation. Failure to document
the type or prevalence of adverse effects in the included
studies of this review makes it harder to assess the
acceptability of iron supplementation for the target
groups, or to begin to address the balance of risk and
benefit. However, the lack of an excessive risk of drop-
out in the participants taking iron supplements com-
pared with placebo suggests that any experienced side
effects were not severe enough for participants to cease
participating, although they may have surreptitiously
reduced their intake of the iron supplements. Compli-
ance was not well addressed in the included studies.
A range of cognitive tests were used in the studies
reviewed. The cognitive domain assessed by each test
was determined on the basis of the description of the
test features. These were not always sufficiently detailed
to permit confident classification. Some researchers clas-
sified ostensibly similar tests as measuring quite differ-
ent cognitive domains. For instance the ‘E-test’ carried
out in Elwood [20] and the ‘clerical task’ carried out in
the studies by Gopaldas and Kashyup [21,23] are, on the
basis of their description, very similar. However, the E-
test is reported to be a test of ‘vigilance, concentration
and a degree of dexterity’, while the clerical task is said
to test ‘attention, concentration and discrimination’.
Moreover, the tests used in the cognitive domains of
attention and vigilance are similar in some aspects to
Raven’s Colour Progressive Matrices which, although a
proxy for IQ and classified as such here, also showed
positive effects of iron supplementation in those with
anaemia. We addressed this by allocating the domains
ourselves from the descriptions of the tests, indepen-
dently of classifications provided in the published
papers.
A large number of cognitive measures were employed
across the studies with some cognitive domains exam-
ined more frequently than others e.g. tests of verbal
memory and IQ and attention were most common. Not
all studies assessed more than one aspect of cognitive
function and the timing of tests post-intervention also
varied. The cognitive tests employed in the studies were
fairly limited, and these were not necessarily selected for
their sensitivity to nutrient intervention or change over
time. Some studies used global neuropsychological tests,
more usually employed for diagnostic purposes or to
ascertain a stable measure of intellectual function.
Across studies, tests were not readily comparable and
accuracy and error rates were not provided by all stu-
dies, and the validity, reproducibility or cultural/lan-
guage appropriateness of these tests were rarely
discussed. To partially address these issues we restricted
the outcomes assessed in this review to the most objec-
tive and valid available in the literature (excluding for
example teacher or parent ratings of behaviour, which
can be highly volatile), but outcome measures were not
ideal.
Although ecologically valid, end of year school perfor-
mance may not provide the most sensitive indicator of
the effect of iron supplementation and many studies
which used scholastic performance as an outcome did
not control for other factors which are likely to influ-
ence school grade, including home environment, paren-
tal involvement, school system and quality. The nature
of the testing situation is important. Teacher or
researcher administered tests, especially where the tester
is not blind to the treatment arm, may positively influ-
ence the performance of the active treatment group
[40]. Computerised, individual and blind testing can
minimise these experimenter effects. With such limited
numbers of included studies there were too few data to
address the effects of specific types of test or types of
administration.
A recent systematic review of the effects of breakfast
on cognitive performance [41] concluded that breakfast
consumption improved verbal fluency and memory
tasks in nutritionally vulnerable children, particularly
short term recognition, memory search and measures
of visual perception. These verbal fluency and memory
tasks, which appeared susceptible to nutritional inter-
vention, were not well represented in the studies
reported here. Moreover, little consideration was given
to motivation and effort including the ability to sustain
performance over time which might be influenced by
long term supplementation or indeed study participa-
tion. Sustaining concentration and retaining informa-
tion are cognitive processes of key importance for
scholastic achievement or other long measures of per-
formance. This may be a partial explanation of why
positive effects of iron supplementation were clearest
in those with deficiencies which were corrected by the
intervention.
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Five studies were identified that could not be included
in the meta-analyses. This was because the outcomes
were reported as z-scores or were adjusted (both of
these ways of analysing the data are appropriate, but
they render the data incomparable in meta-analysis), or
because of a lack of variance data. Inclusion of the
results of these studies in the meta-analyses, had we
been able to retrieve these data in an appropriate for-
mat, could have either reinforced or negated the results
of the analyses. This, along with some suggestion of
publication bias (see Figure 4) suggests that the true
effect of iron supplementation on cognitive outcomes is
unclear.
In some studies (where SF had not been measured) it
was not clear that anaemia was due to iron deficiency,
however results did not alter when the one study which
did not show an effect of iron supplementation was
removed. Another area of uncertainty was the nutri-
tional status of participants aside from iron status,
which was assessed in most studies. Iron supplementa-
tion may be less effective where there are a number of
nutritional problems at baseline (all of which may be
contributing to cognitive limitations) than where partici-
pants are nutritionally replete except for variations in
iron status. For example, iron and zinc deficiencies often
occur together, and zinc deficiency can be exacerbated
with high dose iron supplements [42]. As zinc may also
play a role in cognitive function, iron supplementation
could exacerbate cognitive deficits [43]. This may be
reflected in different effects in developing compared to
developed countries, but is more likely to reflect differ-
ences between individuals within the studies. A related
issue, raised by the late Professor John Beard when he
replied to our requests for further information on one
of his included studies, was whether an intention to
treat analysis of the data is valid, or whether we should
be assessing the effects of iron supplementation only in
individuals whose iron status demonstrably improves.
This is a well-worn argument between analysis by inten-
tion to treat (effectiveness) and by per protocol analysis
(efficacy), and the two types of analysis answer different
questions. The intention to treat analysis, where all
those randomised to the intervention are analysed (and
compared to all those randomised into the control
group) assesses the effectiveness of an intervention (in
this case iron supplementation) on the whole group of
potential recipients. It takes into account that some
individuals may not take the treatment for a variety of
reasons, and some may experience side effects, but
assesses the effect overall in the whole group. The per
protocol analysis would assess efficacy - the effect only
in those individual participants who clearly respond to
treatment with a Hb or SF rise (and would omit those
who experience such increases in the control group), so
is assessing the effect of a specific improvement in bio-
markers of iron status as functional iron (Hb) or storage
iron (SF), rather than the overall effectiveness of supple-
mentation. The difficulty with this approach is that
before providing the supplement it is not possible to
predict whether any one individual will respond with
the required iron status change. Several people may
have to be supplemented to assess effects in just one
person. Assuming that there is a relationship between
iron status and a cognitive domain, the per protocol
approach is more likely to identify the effect with small
sample sizes, but will also overstate the effect size when
a population are considered as a whole [44]. Not enough
studies carried out a per protocol analysis for us to carry
out an alternative analysis on this basis in the review,
although it would have been interesting to do this.
Overall, it is our view that, as individual response to
iron treatment (efficacy) cannot be pre-judged, that an
intention to treat analysis (effectiveness) is the more
useful when considering treatment of an at-risk group,
but a per protocol analysis of small studies may help in
understanding whether a larger RCT of such a group
using an intention to treat analysis would be worthwhile.
Summary
We found some evidence that iron supplementation
improved attention and concentration in adolescents
and women, regardless of baseline level of iron status.
Iron supplementation also improved IQ in women and
children who were anaemic at baseline, but had no
effect in other groups or on other cognitive domains.
Further well powered, blinded and independently funded
studies of at least one year’s duration in children, ado-
lescents, adults and older people with varying levels of
baseline iron status and using well validated tests of
cognition are needed to confirm and extend these
results.
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